ESC Premium Access

Efficacy and safety of inclisiran in patients with polyvascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised controlled trials

Congress Presentation

About the speaker

Professor Wolfgang Koenig

German Heart Center of Munich, Munich (Germany)
24 presentations
0 follower

1 more presentation in this session

A view to the future: approach to vulnerable plaque and/or vulnerable patients

Speaker: Professor R. Byrne (Dublin, IE)


Access the full session

Evolving frontiers for coronary artery disease

Speakers: Professor W. Koenig, Professor R. Byrne

About the event


ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb